Avricore Health Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 0.629241 million compared to CAD 0.042736 million a year ago. Net loss was CAD 0.191512 million compared to CAD 0.185678 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.135 CAD | +3.85% | -12.90% | -20.59% |
Apr. 04 | Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations | MT |
2023 | Avricore Health Provides Update on Q3 | MT |
1st Jan change | Capi. | |
---|---|---|
-20.59% | 9.85M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AVCR Stock
- News Avricore Health Inc.
- Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023